- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
Collaboration aims to accelerate biomarker discovery, strengthen translational research capabilities, and support scalable clinical validation AUSTIN, TX AND CLEVELAND, OH / ACCESS Newswire / May 26, 2026 / Aspira Women’s Health Inc. (OTCQX:AWHL) (“Aspira” or the “Company”), a bio-analytical company focused on the development of AI-powered, noninvasive diagnostics for women’s health, and Cleveland Clinic have signed an agreement…
AUSTIN, TX / ACCESS Newswire / April 23, 2026 / Aspira Women’s Health Inc. (“Aspira”) (OTCQB:AWHL), an AI-enhanced bio-analytics company focused on the development of noninvasive gynecologic disease diagnostics and disease management tools, today announced it is completing the buildout of its molecular laboratory in Q2 2026, marking a major operational milestone that accelerates development and future commercialization…
AUSTIN, TX / ACCESS Newswire / November 14, 2025 / Aspira Women’s Health Inc. (“Aspira”) (OTCQX:AWHL), an AI enhanced bio-analytics based women’s health company focused on delivering leading noninvasive gynecologic disease diagnostic and disease management tools, announced today its results of operations for the three and nine-month periods ended September 30, 2025. September Q3 Highlights: Aspira reported relatively…
Aspira Executes New, Scalable Laboratory Services Agreement in One of the Largest Markets in the US AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / October 29, 2025 / Aspira Women’s Health Inc., abio-analytical-based women’s health company focused on gynecologic disease diagnostics, today announced it has executed a new laboratory services agreement with University of Texas Medical Branch…
NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Aspira Women’s Health Inc. (OTCQX: AWHL), an AI enhanced bio-analytical based women’s health company, has qualified to trade on the OTCQX® Best Market. Aspira Women’s Health Inc. upgraded to OTCQX from the…
$2.95 Million PIPE $112 thousand warrant exercise   AUSTIN, Texas, September 18, 2025 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”) (OTCQB: AWHL), an AI enhanced bio-analytics based women’s health company focused on delivering leading noninvasive gynecologic disease diagnostics and disease management tools, today announced that it has received equity capital totaling $3.06 million from…
New Executive Brings 20+ Years of Accounting, Capital Markets & Biotechnology Experience   AUSTIN, Texas, September 4, 2025 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira” or the “Company”) (QTCQB: AWHL), an AI enhanced bio-analytical based women’s health company focused on delivering the leading tools critical to gynecologic disease diagnostics and disease management, today announced…
AUSTIN, TX / ACCESS Newswire / August 13, 2025 / Aspira Women’s Health Inc. (“Aspira”) (OTCQB:AWHL), an AI enhanced bio-analytics based women’s health company focused on delivering leading noninvasive gynecologic disease diagnostic and disease management tools, announced today its results of operations for the three and six months ended June 30, 2025. The Company also reported early progress…
AUSTIN, TX / ACCESS Newswire / July 15, 2025 / Aspira Women’s Health Inc. (“Aspira” or the “Company”) (QTCQB:AWHL), an AI enhanced bio-analytical based women’s health company focused on delivering the leading tools critical to gynecologic disease diagnostics and disease management, today announced the appointment of Jane Pine Wood to the Board of Directors, effective July 11, 2025.…
Aspira and Dorsata Launch Clinical Workflow Tool for Adnexal Masses, Now Live for All Dorsata Clients, Adnexal Mass Evidence-Based Decision Support AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / June 17, 2025 / Aspira Women’s Health Inc. a bio-analytical-based women’s health company focused on gynecologic disease diagnostics, and Dorsata, a leading clinical decision-support and provider workflow platform…
